Delivery Order SPE2DE24D0013-SPE2D626F93SC
Award Date 3/9/26
Potential Completion Date 3/16/26
Potential Value $7.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Sunnyvale, CA 94089, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency Medical Supply Chain issued a $10,200 delivery order to Cepheid on March 6, 2026, for molecular diagnostic supplies. The order is issued under a parent Indefinite Delivery Contract with the Department of Veterans Affairs VISN 6, valued at $32.8 million and extending through September 30, 2030, for provision of molecular diagnostic testing system reagents and assays to support VISN 6 medical center laboratories. Place of performance is Sunnyvale, CA 94089. The...
- The Defense Logistics Agency Medical Supply Chain issued a $4,486.68 delivery order to Cepheid on March 6, 2026, with ultimate completion by March 20, 2026. The order is firm fixed price with no set-aside designation and performance in Sunnyvale, CA. The source does not identify the parent IDV or IDIQ vehicle name under which this order was issued. Place of performance is Sunnyvale, California. Cepheid, a manufacturer of advanced molecular diagnostic systems and reagents headquartered in...
- <p>The Defense Logistics Agency Medical Supply Chain issued a $6,072.00 delivery order to Cepheid on March 9, 2026, for molecular diagnostic supplies with an ultimate completion date of March 16, 2026.</p> <p>Place of performance is Sunnyvale, CA. The order is firm fixed price with no set-aside. Cepheid manufactures advanced molecular diagnostic systems and reagents, including its GeneXpert platform used across federal healthcare agencies for infectious disease testing.</p>
- The Defense Logistics Agency Medical Supply Chain issued a $4,607 delivery order to Cepheid on March 5, 2026, with ultimate completion on March 12, 2026, for molecular diagnostic supplies under a firm fixed-price structure. Place of performance is Sunnyvale, CA. The order carries no set-aside designation. Cepheid, headquartered in Sunnyvale, is a manufacturer of advanced molecular diagnostic systems and reagents, including its GeneXpert diagnostic platform and associated testing capabilities for...
- The Defense Logistics Agency Medical Supply Chain issued a $6,800 delivery order to Cepheid on March 9, 2026, for molecular diagnostic supplies, with a ceiling value matching the obligated amount and an ultimate completion date of March 16, 2026. Place of performance is Sunnyvale, CA 94089. The order is firm fixed price with no set-aside designation. The source does not explicitly identify the parent IDV vehicle name or confirm which of Cepheid's established VA indefinite delivery contracts this...
- The Defense Logistics Agency Medical Supply Chain issued a $7,480 delivery order to Cepheid on March 6, 2026, for molecular diagnostic testing supplies. The order, which is firm fixed price with no set-aside, is placed against a parent Indefinite Delivery Contract held by Cepheid with the Department of Veterans Affairs VISN 6, valued at $32.8 million and extending through September 30, 2030, for provision of molecular diagnostic testing system reagents and assays to support VISN 6 medical center...
- The Defense Logistics Agency Medical Supply Chain issued a $13,600 delivery order to Cepheid on February 12, 2026, under the XPRS4PLEX-10 contract for molecular diagnostic supplies. Place of performance is Sunnyvale, CA 94089. The order is firm fixed price with an ultimate completion date of February 20, 2026. This delivery order is issued against Cepheid's Indefinite Delivery Contract with the VA Veterans Integrated Service Network (VISN) system for provision of molecular diagnostic testing...
- The Defense Logistics Agency Medical Supply Chain issued a $33,180.48 delivery order to Cepheid on February 18, 2026, for molecular diagnostic supplies with an ultimate completion date of February 25, 2026. This is a firm fixed-price delivery order with no set-aside. Place of performance is Sunnyvale, CA 94089. The order ceiling value is $33,180.48. Cepheid is a manufacturer of advanced molecular diagnostic systems and reagents, headquartered in Sunnyvale, California, specializing in...
- The Defense Logistics Agency's Medical Supply Chain issued a $13,600 delivery order to Cepheid on March 9, 2026, for diagnostic testing supplies, with an ultimate completion date of March 16, 2026. Place of performance is Sunnyvale, CA. The order is firm fixed price with no set-aside designation. Cepheid is a for-profit manufacturer of advanced molecular diagnostic systems and reagents, headquartered in Sunnyvale, California, and serves as a primary federal supplier of diagnostic solutions to...
- The Defense Logistics Agency Medical Supply Chain issued a $6,800 delivery order to Cepheid on March 9, 2026, for diagnostic testing supplies under firm fixed-price terms. The order is due for completion by March 16, 2026. Place of performance is Sunnyvale, CA 94089. This is a child delivery order call against Cepheid's existing contract vehicle; the source identifies Cepheid as holding prime IDIQs with the Department of Veterans Affairs (VISN 17 and VISN 6) for molecular diagnostic reagents and...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F93SCDelivery Order
The Defense Logistics Agency Medical Supply Chain issued a $7,480 delivery order to Cepheid on March 9, 2026, for molecular diagnostic supplies, with an ultimate completion date of March 16, 2026. Place of performance is Sunnyvale, CA 94089. The order is firm fixed price with no set-aside. The source does not identify the parent vehicle name; however, Cepheid holds established Indefinite Delivery Contracts with the Department of Veterans Affairs for molecular diagnostic testing system reagents and assays, demonstrating the company's role as a core federal supplier of GeneXpert diagnostic platform solutions and associated testing capabilities across VA medical centers and integrated service networks.
Generated 6/7/26, 9:52 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.5k | 3/8/26 |